Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Non-Invasive Temporally Interfering Electric Fields Stimulation for Epilepsy and Healthy Adults

Official title: Cognitive and Electrophysiological Assessment of Non-Invasive Temporally-Interfering Electric Fields Stimulation (TIEFS)

Run by University of California, Davis · NCT07663578 · Data updated 2026-11-12

This test will see if a non-surgical brain stimulation method called TIEFS can change brain activity and thinking skills in adults with epilepsy and in healthy adults.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment15 (estimated)
SponsorUniversity of California, Davis
Academic / other
Locations1 site (Sacramento, California)
StatusRecruiting
StartedApril 16, 2025
Main results expectedApril 15, 2027
Study endsApril 15, 2027
Registry record updatedJune 23, 2026
Trial IDNCT07663578 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Eligible adults aged 18-65 with epilepsy undergoing intracerebral monitoring or healthy adults without seizure history, who can consent and complete cognitive tasks.

Probably not a fit

Some participants may not experience cognitive benefits or may not tolerate stimulation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of Temporally Interfering Electric Fields Stimulation (TIEFS) on brain signals and cognitive functions. It includes adults with epilepsy undergoing intracerebral monitoring and healthy controls, comparing brain activity and performance on memory, attention, language, and movement tasks before and after brief TIEFS sessions. Researchers will monitor safety and tolerability while collecting electrophysiological data and cognitive outcomes. The trial uses scalp electrodes to deliver the stimulation without any invasive procedure. Participation requires English or Spanish fluency and the ability to consent and complete tasks.

Why it matters

Potential benefit: If successful, TIEFS could offer a non-invasive option to modulate brain activity and support cognitive function in epilepsy and possibly other populations.

How similar studies have gone: Prior non-invasive brain stimulation approaches have shown mixed but growing evidence of modulating brain activity and cognition in some populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients (age 18-65 years of age) undergoing an intracerebral electrophysiology study for epilepsy pre-surgical evaluation are eligible for inclusion.
* For healthy control subjects are also eligible for inclusion (Scalp EEG measurements).
* Participants must be able to sufficiently speak and understand English or Spanish for consent and be able to understand and complete cognitive tasks.
* All subjects must have the ability to give valid informed consent.

Exclusion Criteria:

* No pregnant women will be recruited.
* People with implanted electrical devices such as Deep Brain Stimulation devices or Pacemakers.
* No prisoners will be recruited.

Where it's running

  • University of California Davis Medical Center
    Sacramento, California, United States
    Recruiting

Study contacts

  • Principal investigator: Nigel P Pedersen, MBBS — University of California Davis, School of Medicine, Neurology Department
  • Study coordinator: Nigel P Pedersen, MBBS
  • Email: nppedersen@health.ucdavis.edu
  • Phone: 617-462-8120

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.